Novel DR Marker
By The Ophthalmologist
September 2, 2025
Postprandial C‑peptide to glucose ratio represents novel systemic marker for diabetic retinopathy risk in T2DM patients
1 min read
False
Advertisement
Research & Innovations
Neurostimulated Tears
By The Ophthalmologist
August 28, 2025
Targeting TRPM8: a novel therapeutic angle for Dry Eye Disease
2 min read
FDA Agreement for AXPAXLI Registrational Trial
By The Ophthalmologist
August 22, 2025
Ocular Therapeutix secures FDA agreement on NPDR trial design
1 min read
Osteoporosis and AMD Risk
By The Ophthalmologist
August 22, 2025
Study explores the link between osteoporosis and AMD with data taken from NHANES
2 min read
Wide Disparities in IRD Diagnosis
By The Ophthalmologist
August 20, 2025
Nationwide study shows jump in prevalence of IRDs
2 min read
Sleep, the Best Medicine?
By The Ophthalmologist
August 19, 2025
IOVS study highlights sleep as modifiable risk factor in age-related ocular disease
1 min read
Exonate Initiates Phase IIb Trial of EXN407 for Diabetic Eye Disease
August 12, 2025
EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema
1 min read
Predicting Normal-Tension Glaucoma
August 12, 2025
New IOVS study recommends a polygenic approach towards advancing risk stratification in normal-tension glaucoma
2 min read
Diet & Sleep Links to Glaucoma
By The Ophthalmologist
August 11, 2025
Diet, sleep, and biochemical mediators: novel insights into glaucoma pathogenesis
Phase III Data on Bausch + Lomb's LUMIFY®
August 8, 2025
Publication of phase III data on LUMIFY® preservative-free redness reliever eye drops
1 min read
Browse by Subspecialties
False
Advertisement